Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13Neoplasms 12Colorectal Neoplasms 12Pain 11Pain, Postoperative 9Prostatic Neoplasms 7Lung Neoplasms 7Agnosia 6Colonic Neoplasms 5Cancer Pain 5Neuralgia 4Keratosis, Actinic 4Head and Neck Neoplasms 4Liver Neoplasms 3Leiomyoma 3Chronic Pain 3Thyroid Neoplasms 2Stomatitis 2Stomach Neoplasms 2Recurrence 2Pilonidal Sinus 2Oropharyngeal Neoplasms 2Neuroma 2Neoplasm Metastasis 2Myofibroma 2Mucositis 2Inflammatory Bowel Diseases 2Ileus 2Diverticulitis 2Carcinoma, Non-Small-Cell Lung 2

Interventions

Specimen Handling 2Nivolumab 2toripalimab 1talimogene laherparepvec 1pembrolizumab 1bicalutamide 1Magnetic Resonance Spectroscopy 1Lidocaine 1Ipilimumab 1Imiquimod 1Fluorescein 1CTLA-4 Antigen 1Biopsy 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Paget Disease, Extramammary × Lidocaine × Clear all
NCT02385188 2020-01-02

Topical 5% Imiquimod Cream for Vulvar Paget's Disease

University Medical Center Nijmegen

Phase 3 Completed
25 enrolled

Paget Disease, Extramammary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡